Joel T. Funk, MD, FACS

Associate Professor, Urology
Associate Director of Perioperative Services, BUMCT/S
Chief of Surgical Services, Banner University Medical Center – South Campus
Director of Urology, Banner University Medical Center – South Campus

Dr. Funk is a nationally and internationally recognized expert and key thought leader in laser prostatectomy and female urology. He was the first urologist to perform a holmium prostatectomy in Southern Arizona and remains one of a handful of surgeons nationwide, performing at least 100 of these procedures a year.

Dr. Funk has extensive experience in the surgical and non-surgical management of prostate and bladder outlet obstruction in men. Furthermore, he is an active female urology specialist with expertise in robotic sacrocolpopexy, vaginal mesh excision and anti-incontience surgery. After completing his residency at the College of Medicine – Tucson, he realized Tucson was home and joined the clinical faculty in the Department of Surgery. He later completed additional training in laser prostatectomy at Addensbrooke Hospital in Cambridge in 2009.

Degree(s)

  • MD: Feinberg School of Medicine at Northwestern University, 2001
  • BS: Aquinas College, Grand Rapids, Michigan
Residency
University of Arizona College of Medicine – Tucson, Urology, 2007
University of Arizona College of Medicine – Tucson, General Surgery, 2003
Board Certifications
American Board of Urology, 2011
Honors and Awards
College of Medicine – Tucson Clinical Excellence Award, 2018
Bodinger Stegmann Award-WSAUA, Best Tips/Tricks, 2004
Resident Teaching Award, Department of Surgery, 2002
Clinical Specialties
Female Pelvic Medicine and Reconstructive Surgery
Benign Prostate Obstruction
Male Voiding Dysfunction
Neurourology and Voiding Dysfunction
Stone Disease
Research Interests

MRI imaging and evaluation of pelvic organ prolapse, long-term outcomes from HoLEP, prostate cancer risk, histologic evaluation of the pathogenesis of benign prostatic hypertrophy, MR fusion biopsy in the diagnosis and decision-making of prostate cancer